| # | Drug | Count |
|---|---|---|
| 0 | MONTELUKAST | 50 |
| 1 | MONTELUKAST SODIUM | 19 |
| 2 | ALBUTEROL SULFATE | 17 |
| 3 | BECLOMETHASONE DIPROPIONATE | 14 |
| 4 | IPRATROPIUM BROMIDE | 11 |
| 5 | RISPERIDONE | 8 |
| 6 | LAMOTIRIGINE | 7 |
| 7 | LAMOTRIGINE | 7 |
| 8 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 7 |
| 9 | LAMOTRIGINE EXTENDED-RELEASE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASTOR OIL | 1 | 0.0052 |
| 1 | BECLOMETHASONE DIPROPIONATE | 14 | 0.0024 |
| 2 | TETRABENAZINE | 6 | 0.0008 |
| 3 | VILOXAZINE HYDROCHLORIDE | 1 | 0.0008 |
| 4 | TERBUTALINE SULFATE | 1 | 0.0005 |
| 5 | BRIVARACETAM | 5 | 0.0005 |
| 6 | ONASEMNOGENE ABEPARVOVEC-XIOI | 1 | 0.0004 |
| 7 | IPRATROPIUM BROMIDE | 11 | 0.0003 |
| 8 | DEFERIPRONE | 1 | 0.0003 |
| 9 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 6 | 0.0048 |
| 1 | Leukotriene Receptor Antagonist [EPC] | 15 | 0.0005 |
| 2 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 4 | Cannabinoid [EPC] | 1 | 0.0001 |
| 5 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 7 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 8 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 9 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |